Background
This study was designed to test the hypothesis that cortisol mediates the relationship
between bone density and depression in postmenopausal women.
Methods
Nineteen women aged 52–79 who had been assessed for bone mineral density by dual-energy
x-ray absorptiometer (DEXA) were evaluated for depression and anxiety. Diurnal and
stress-induced measures of salivary cortisol were obtained during the following week
and at a laboratory session involving a speech task.
Results
Nine volunteers reported depression while 10 were never depressed. Ever depressed
women had significantly lower total lumbar and right femur DEXA Z scores than never
depressed (t(17) = 2.5, p = .019 and t(17) = 2.06, p = .05, respectively). Ever depressed women demonstrated a significant increase in
salivary cortisol (area under the curve (AUC) = 27.83, SD = 37.64) compared to never
depressed women (AUC = -13.34, SD = 19.55) (t(17) = -3.041, p = .007) during a psychological challenge. There were significant inverse relationships
between salivary cortisol AUC values and bone density Z scores at every measured bone site. Mediation analyses suggest that 51 – 67% of the
association between depression and bone density could be attributed to stress-induced
changes in cortisol.
Conclusions
Cortisol hypersecretion in response to stress may, in part, explain the impact of
depression on bone density in post-menopausal women.
Key words
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Biological PsychiatryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Corticosteroid-induced osteoporosis.Am J Med Sci. 1997; 313: 41-49
- Glucocorticoids and osteoporosis.Endocrinol Metab Clin North Am. 1994; 23: 641-654
- Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis.Arthritis Rheum. 1996; 39: 1791-1801
- Cortisol secretion and dexamethasone response in depression.Am J Psychiatry. 1981; 138: 1218-1221
- An inventory for measuring clinical anxiety.J Consult Clin Psychol. 1988; 56: 893-897
- Psychometric properties of the Beck Depression Inventory.Clinical Psychological Review. 1988; 8: 77-100
- The dexamethasone suppression test for melancholia.Br J Psychiatry. 1982; 140: 292-304
- Pituitary-adrenal function in depression.Lancet. 1968; 1: 1373-1374
- Revised NEO Personality Inventory (NEOPI-R) and NEO Five-Factor Inventory (NEO-FFI). Psychological Assessment Resources, Inc, Odessa, FL1991
- Profiles of endogenous circulating cortisol and bone mineral density in healthy elderly men.J Clin Endocrinol Metab. 1999; 84: 3058-3063
- Effects of major depression, aging and gender upon calculated diurnal free plasma cortisol concentrations.Stress. 1998; 2: 281-287
- Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing’s disease.Clin Endocrinology. 1998; 48: 655-662
- The dexamethasone suppression test in the clinical setting.Am J Psychiatry. 1983; 140: 586-589
- Mood disorders and medical illness.Biol Psychiatry. 2003; 54: 177-180
- The effect of acute behavioral stress in social phobic patients and normal controls.Biol Psychiatry. 2001; 50: 254-259
- The endocrinology of melancholic and atypical depression.Proceedings of the Association of American Physicians. 1998; 111: 22-34
- Normalization of dexamethasone suppression test.Biol Psychiatry. 1980; 15: 449-458
- The role of early adverse experience and adulthood stress in the prediction of neuroendocrine stress reactivity in women.Depress Anxiety. 2002; 15: 117-125
- Osteoporosis.South Med J. 2000; 93: 2-18
- Process analysis.Eval Rev. 1981; 5: 602-619
- Glucocorticoid-induced osteoporosis.Ann Intern Med. 1990; 112: 352-364
- Confidence simulation study of mediated effect measures.Multivariate Behavioral Research. 1995; 30: 41-62
- Manual for the Profile of Mood States. Educational & Industrial Testing Service, San Diego, CA1971
- BMD in women with depression.N Engl J Med. 1996; 335: 1176-1181
- Bootstrapping. Sage Publications, Inc, Newbury Park, CA1993
- Correlation between the dexamethosone suppression test in depressed patients and clinical response.Am J Psychiatry. 1984; 141: 247-249
- Osteoporosis prevention, diagnosis, and therapy.JAMA. 2001; 285: 785-795
- Elevated salivary cortisol in the evening in healthy elderly men and women.J Gerontol A Biol Sci Med Sci. 1999; 54: M479-M483
- The association of bone mineral density and depression in an older population.Journal of the American Geriatric Society. 2001; 49: 732-736
- Low lumbar BMD in patients with major depression.Am J Psychiatry. 1994; 151: 1691-1693
- Lumbar BMD in patients with major depression.Am J Psychiatry. 2000; 157: 118-120
- The dexamethasone suppression test in generalised anxiety disorder.Br J Psychiatry. 1986; 149: 320-322
- Bone mineral density thresholds for pharmacological intervention to prevent fractures.Arch Intern Med. 2004; 164: 1108-1112
- Measurement of social-evaluative anxiety.J Consult Clin Psych. 1969; 33: 448-457
- Sensitization of the hypothalamic-pituitary-adrenal axis in posttraumatic stress disorder.Ann N Y Acad Sci. 1997; 821: 57-75
- Glucocorticoid-induced osteoporosis.Steroids. 1998; 63: 344-348
Article Info
Publication History
Published online: March 10, 2005
Accepted:
December 20,
2004
Received in revised form:
December 9,
2004
Received:
July 29,
2004
Identification
Copyright
© 2005 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
